ADAMS ERIC A has filed 8 insider transactions across 1 company since March 2023.
Most recent transaction: a grant/award of 35000 shares of InMed Pharmaceuticals Inc. ($INM) on December 19, 2025.
Activity breakdown: 1 open-market purchase and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 19, 2025 | InMed Pharmaceuticals Inc. | $INM | ADAMS ERIC A | President & CEO | A | Employee Stock Option (Right to Buy) | 35000 | $0.00 | 49,050.0000 | 3,954,549 | 249.11% | 0.89% |
| Dec. 15, 2025 | InMed Pharmaceuticals Inc. | $INM | ADAMS ERIC A | President & CEO | H | Employee Stock Option (Expiration) | 250 | $0.00 | 14,050.0000 | 3,954,549 | 1.75% | 0.01% |
| Dec. 20, 2024 | InMed Pharmaceuticals Inc. | $INM | ADAMS ERIC A | President & CEO | A | Employee Stock Option (Right to Buy) | 6250 | $0.00 | 14,300.0000 | 620,127 | 77.64% | 1.01% |
| May 27, 2024 | InMed Pharmaceuticals Inc. | $INM | ADAMS ERIC A | President & CEO | H | Employee Stock Option (Expiration) | 1139 | $0.00 | 161,000.0000 | 480,649 | 0.70% | 0.24% |
| Feb. 20, 2024 | InMed Pharmaceuticals Inc. | $INM | ADAMS ERIC A | President & CEO | P | Common Stock | 41600 | $0.36 | 43,959.0000 | 398,673 | 1763.46% | 10.44% |
| Dec. 23, 2023 | InMed Pharmaceuticals Inc. | $INM | ADAMS ERIC A | President & CEO | A | Employee Stock Option (Right to Buy) | 136000 | $0.00 | 162,139.0000 | 166,410 | 520.30% | 81.73% |
| May 16, 2023 | InMed Pharmaceuticals Inc. | $INM | ADAMS ERIC A | President & CEO | H | Employee Stock Option (Expiration) | 1818 | $0.00 | 26,139.0000 | 3,328,191 | 6.50% | 0.05% |
| March 8, 2023 | InMed Pharmaceuticals Inc. | $INM | ADAMS ERIC A | President & CEO | H | Employee Stock Option (Expiration) | 545 | $0.00 | 27,957.0000 | 2,300,526 | 1.91% | 0.02% |